retatrutide development status eli lilly fda approval Lilly's drug, not approved, accessed through experimental treatment program Eli Lillys retatrutide what is

At Regency Medical Spa, we prioritize your well-being and are dedicated to providing comprehensive guidance and support throughout your weight management journey

It is the foundation of several breakthrough medications that are revolutionizing the treatment of obesity and type 2 diabetes

GLP-1 Symptoms That Are Commonly Misinterpreted as Hypoglycemia Many GLP-1 side effects overlap with classic low blood sugar symptoms, which can be confusing

Real Results: In the most recent head-to-head study comparing tirzepatide to semaglutide, people taking tirzepatide lost an average of 20.2% of their body weight compared to 13.7% with semaglutide over 72 weeks

Gut hormones-based pharmacology: novel formulations and future possibilities for metabolic disease therapy